These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Selective stenting in subintimal angioplasty: analysis of primary stent outcomes. Schmieder GC; Richardson AI; Scott EC; Stokes GK; Meier GH; Panneton JM J Vasc Surg; 2008 Nov; 48(5):1175-80; discussion 1180-1. PubMed ID: 18778911 [TBL] [Abstract][Full Text] [Related]
33. Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia. Kickuth R; Keo HH; Triller J; Ludwig K; Do DD J Vasc Interv Radiol; 2007 Jun; 18(6):703-8. PubMed ID: 17538131 [TBL] [Abstract][Full Text] [Related]
35. Midterm outcomes of subintimal angioplasty supported by primary proximal stenting for chronic total occlusion of the superficial femoral artery. Hong SJ; Ko YG; Kim JS; Hong MK; Jang Y; Choi D J Endovasc Ther; 2013 Dec; 20(6):782-91. PubMed ID: 24325694 [TBL] [Abstract][Full Text] [Related]
36. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis. Mori S; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H J Endovasc Ther; 2015 Jun; 22(3):341-9. PubMed ID: 25862363 [TBL] [Abstract][Full Text] [Related]
37. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials. Ohki T; Yokoi H; Kichikawa K; Kimura T; Snyder SA; Ragheb AO; O'Leary EE; Jaff MR; Ansel GM; Dake MD J Endovasc Ther; 2014 Oct; 21(5):644-53. PubMed ID: 25290792 [TBL] [Abstract][Full Text] [Related]
38. Drug-Eluting vs Standard Balloon Angioplasty for Iliac Stent Restenosis: Midterm Results. Stahlhoff S; Donas KP; Torsello G; Osada N; Herten M J Endovasc Ther; 2015 Jun; 22(3):314-8. PubMed ID: 25991767 [TBL] [Abstract][Full Text] [Related]